Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Value Health ; 18(5): 605-13, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26297088

ABSTRACT

BACKGROUND: Several minimally invasive techniques for cardiac output monitoring such as the esophageal Doppler (ED) and arterial pulse pressure waveform analysis (APPWA) have been shown to improve surgical outcomes compared with conventional clinical assessment (CCA). OBJECTIVE: To evaluate the cost-effectiveness of these techniques in high-risk abdominal surgery from the perspective of the French public health insurance fund. METHODS: An analytical decision model was constructed to compare the cost-effectiveness of ED, APPWA, and CCA. Effectiveness data were defined from meta-analyses of randomized clinical trials. The clinical end points were avoidance of hospital mortality and avoidance of major complications. Hospital costs were estimated by the cost of corresponding diagnosis-related groups. RESULTS: Both goal-directed therapy strategies evaluated were more effective and less costly than CCA. Perioperative mortality and the rate of major complications were reduced by the use of ED and APPWA. Cost reduction was mainly due to the decrease in the rate of major complications. APPWA was dominant compared with ED in 71.6% and 27.6% and dominated in 23.8% and 20.8% of the cases when the end point considered was "major complications avoided" and "death avoided," respectively. Regarding cost per death avoided, APPWA was more likely to be cost-effective than ED in a wide range of willingness to pay. CONCLUSIONS: Cardiac output monitoring during high-risk abdominal surgery is cost-effective and is associated with a reduced rate of hospital mortality and major complications, whatever the device used. The two devices evaluated had negligible costs compared with the observed reduction in hospital costs. Our comparative studies suggest a larger effect with APPWA that needs to be confirmed by further studies.


Subject(s)
Abdomen/surgery , Arterial Pressure , Blood Pressure Determination/economics , Cardiac Output , Echocardiography, Doppler/economics , Esophagus/diagnostic imaging , Fluid Therapy/economics , Hospital Costs , Monitoring, Intraoperative/economics , Aged , Blood Pressure Determination/instrumentation , Cost Savings , Cost-Benefit Analysis , Decision Support Techniques , Decision Trees , Echocardiography, Doppler/instrumentation , France , Hospital Mortality , Humans , Middle Aged , Models, Economic , Monitoring, Intraoperative/instrumentation , Monitoring, Intraoperative/methods , Monte Carlo Method , National Health Programs/economics , Postoperative Complications/economics , Postoperative Complications/mortality , Postoperative Complications/prevention & control , Predictive Value of Tests , Public Sector/economics , Treatment Outcome
2.
Europace ; 3(4): 304-10, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11678389

ABSTRACT

AIMS: To evaluate whether a single decapolar electrode is a reliable and cost-effective substitute for the 'Halo' catheter to map the circuit and detect bidirectional isthmus block during atrial flutter (AFL) ablation. METHODS AND RESULTS: Twenty-four patients underwent AFL ablation by using the decapolar electrode in the infero-lateral wall of right atrium (group A) while a 'Halo' catheter was used in 11 patients (group B). Both groups had similar clinical characteristics. Anti-clockwise rotation (20 patients), clockwise (3 patients) or both forms of AFL (1 patient) were detected in group A. All patients in group B had anti-clockwise AFL. Bidirectional isthmus block was completed in 22 patients of group A and in 9 of group B (P=NS) while incomplete isthmus block was detected in 2 patients in each group (P=NS). Mean fluoroscopy and procedure time was 27 +/- 47 min, 107 +/- 36 min in group A and 14 +/- 19 min, 114 +/- 65 min in group B (P=NS). AFL relapsed in 3 patients of group A (follow-up 7 +/- 4 months) and in 2 of group B (4 +/- 2 months). CONCLUSION: A single decapolar electrode is a reliable method to map the circuit and demonstrate bidirectional isthmus block during AFL ablation. The cost of the decapolar electrode is a quarter of that of the 'Halo' catheter. This represents a significant saving particularly for centres with a substantial number of AFL ablations.


Subject(s)
Atrial Flutter/surgery , Catheter Ablation/methods , Electrophysiologic Techniques, Cardiac/economics , Heart Block/diagnosis , Monitoring, Intraoperative/methods , Adult , Aged , Atrial Flutter/diagnosis , Atrial Flutter/physiopathology , Cost-Benefit Analysis , Electrodes/economics , Follow-Up Studies , Heart Atria , Humans , Middle Aged , Monitoring, Intraoperative/economics
3.
Anesth Analg ; 88(4): 723-8, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10195511

ABSTRACT

UNLABELLED: We designed this study to test the hypothesis that methohexital is a cost-effective alternative to propofol for sedation during local anesthesia. Sixty consenting women undergoing breast biopsy procedures under local anesthesia were randomly assigned to receive an infusion of either propofol (50 microg x kg(-1) x min(-1)) or methohexital (40 microg x kg(-1) x min(-1)). The sedative infusion rate was titrated to maintain an observer's assessment of alertness/sedation (OAA/S) score of 3 (with 1 = awake/alert to 5 = asleep). Fentanyl 25 microg i.v. was administered as a "rescue" analgesic during the operation. We assessed the level of sedation (OAA/S score), vital signs, time to achieve an OAA/S score of 3 at the onset and a score of 1 after discontinuing the infusion, discharge times, perioperative side effects, and patient satisfaction. The direct cost of methohexital was lower than that of propofol, based on the milligram dosage infused during the operation. The sedative onset (to achieve an OAA/S score of 3) and the recovery (to return to an OAA/S score of 1) times, as well as discharge times, did not differ between the two groups. Patients receiving methohexital had a significantly lower incidence of pain on initial injection compared with those receiving propofol (10% vs 23%). Because the use of methohexital (29.4 +/- 2.7 microg x kg(-1) x min(-1)) for sedation during breast biopsy procedures has a similar efficacy and recovery profile to that of propofol (36.8 +/- 15.9 microg x kg(-1) x min(-1)) and is less costly based on the amount infused, it seems to be a cost-effective alternative to propofol for sedation during local anesthesia. However, when the cost of the drug infused and drug wasted was calculated, there was no difference in the overall drug cost. IMPLICATIONS: When administered to maintain a stable level of sedation during local anesthesia, methohexital is an acceptable alternative to propofol. However, the overall drug costs were similar with the two drugs.


Subject(s)
Anesthesia, Local , Anesthetics, Intravenous/economics , Hypnotics and Sedatives/economics , Methohexital/economics , Monitoring, Intraoperative/economics , Propofol/economics , Anesthetics, Intravenous/administration & dosage , Female , Heart Rate , Humans , Hypnotics and Sedatives/administration & dosage , Methohexital/administration & dosage , Middle Aged , Premedication/economics , Propofol/administration & dosage , Respiration , Time Factors
4.
Zentralbl Chir ; 121(12): 1041-4, 1996.
Article in German | MEDLINE | ID: mdl-9092225

ABSTRACT

In order to evaluate the relation between costs and benefit of the use of a temporary shunt during surgery of the carotid artery, we analysed 356 patients undergoing 401 operations of the carotid artery in a period from January 1991 to August 1995 in a retrospective study. The morbidity and mortality during hospital stay were 1.75% respectively 0.75% referring to neurological outcome and death. The potential to economize surgery of the carotid artery by recording the somatosensory evoked potentials in order to select the patients requiring a temporary shunt would be 4.1% of the payment which will be payed from 1996 by the social insurance for carotid endarterectomy. These savings can be realized without loss of quality or higher risk for the patient.


Subject(s)
Carotid Stenosis/surgery , Endarterectomy, Carotid/economics , Monitoring, Intraoperative/economics , Aged , Carotid Stenosis/economics , Carotid Stenosis/mortality , Cost-Benefit Analysis , Evoked Potentials, Somatosensory/physiology , Female , Germany , Humans , Male , Middle Aged , National Health Programs/economics , Quality Assurance, Health Care/economics , Retrospective Studies , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL